Frontiers in Pharmacology (May 2018)
Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
- Wei Wang,
- Zheng-Zhu Zhang,
- Yan Wu,
- Ru-Qing Wang,
- Jin-Wu Chen,
- Jing Chen,
- Yan Zhang,
- Ya-Jun Chen,
- Ming Geng,
- Zhong-Dong Xu,
- Min Dai,
- Jin-Hua Li,
- Li-Long Pan
Affiliations
- Wei Wang
- School of Life Science, Hefei Normal University, Hefei, China
- Zheng-Zhu Zhang
- State Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University, Hefei, China
- Yan Wu
- School of Life Science, Hefei Normal University, Hefei, China
- Ru-Qing Wang
- School of Life Science, Hefei Normal University, Hefei, China
- Jin-Wu Chen
- School of Life Science, Hefei Normal University, Hefei, China
- Jing Chen
- School of Life Science, Hefei Normal University, Hefei, China
- Yan Zhang
- School of Life Science, Hefei Normal University, Hefei, China
- Ya-Jun Chen
- School of Life Science, Hefei Normal University, Hefei, China
- Ming Geng
- School of Life Science, Hefei Normal University, Hefei, China
- Zhong-Dong Xu
- School of Life Science, Hefei Normal University, Hefei, China
- Min Dai
- Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui Key Laboratory for Research and Development of Traditional Chinese Medicine, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China
- Jin-Hua Li
- School of Life Science, Hefei Normal University, Hefei, China
- Li-Long Pan
- School of Medicine, Jiangnan University, Wuxi, China
- DOI
- https://doi.org/10.3389/fphar.2018.00459
- Journal volume & issue
-
Vol. 9
Abstract
No abstracts available.Keywords
- (-)-Epigallocatechin-3-gallate
- tetratricopeptide repeat domain protein 39B
- atherosclerosis
- inflammation
- dyslipidemia
